Read Gene SA
WSE:RDG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Acreage Holdings Inc
OTC:ACRDF
|
US |
Read Gene SA
Cash from Operating Activities
Read Gene SA
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Read Gene SA
WSE:RDG
|
Cash from Operating Activities
zł201.7k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
M
|
Mabion SA
WSE:MAB
|
Cash from Operating Activities
-zł40.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
G
|
Genomed SA
WSE:GEN
|
Cash from Operating Activities
zł1.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bioton SA
WSE:BIO
|
Cash from Operating Activities
zł22.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
U
|
Urteste SA
WSE:URT
|
Cash from Operating Activities
-zł5.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
S
|
Synthaverse SA
WSE:SVE
|
Cash from Operating Activities
zł1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Read Gene SA
Glance View
Read-Gene SA engages in the medical research and testing. The company is headquartered in Szczecin, Woj. Zachodniopomorskie. The company went IPO on 2009-02-12. The company is focused on technologies which aim is to detect, prevent and treat malignant tumors. The firm specializes in three fields: chemoprevention, clinical trials and genetic testing. The company offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The firm operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.
See Also
What is Read Gene SA's Cash from Operating Activities?
Cash from Operating Activities
201.7k
PLN
Based on the financial report for Dec 31, 2025, Read Gene SA's Cash from Operating Activities amounts to 201.7k PLN.
What is Read Gene SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-28%
Over the last year, the Cash from Operating Activities growth was -90%. The average annual Cash from Operating Activities growth rates for Read Gene SA have been -17% over the past three years , -28% over the past five years .
